We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCMI icon
10501
National CineMedia
NCMI
$269M
$210K ﹤0.01%
22,939
+14,198
+162% +$240K
PRA
10502
PUT
DELISTED
ProAssurance
PRA
$210K ﹤0.01%
8,900
+1,400
+19% +$32.8K
SPIR icon
10503
CALL
Spire Global
SPIR
$567M
$210K ﹤0.01%
22,650
-1,000
-4% -$12.8K
TGLS icon
10504
Tecnoglass Holdings
TGLS
$1.86B
$210K ﹤0.01%
+11,954
New +$254K
UFPT icon
10505
UFP Technologies
UFPT
$2.49B
$210K ﹤0.01%
+2,636
New +$194K
WDNA icon
10506
WisdomTree BioRevolution Fund
WDNA
$2.75M
$210K ﹤0.01%
+12,106
New +$219K
GRTS
10507
CALL
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$210K ﹤0.01%
86,600
+34,500
+66% +$90.6K
AMJ
10508
CALL
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$210K ﹤0.01%
+11,100
New +$234K
CATH icon
10509
Global X S&P 500 Catholic Values ETF
CATH
$1.36B
$209K ﹤0.01%
4,560
-617
-12% -$31K
DBI icon
10510
PUT
Designer Brands
DBI
$299M
$209K ﹤0.01%
16,000
-71,000
-82% -$1.02M
DNLI icon
10511
PUT
Denali Therapeutics
DNLI
$3.9B
$209K ﹤0.01%
+7,100
New +$186K
GLRY icon
10512
Inspire Growth ETF
GLRY
$169M
$209K ﹤0.01%
+9,956
New +$224K
MIST icon
10513
CALL
Milestone Pharmaceuticals
MIST
$137M
$209K ﹤0.01%
+35,200
New +$216K
VXRT
10514
PUT
DELISTED
Vaxart
VXRT
$209K ﹤0.01%
59,600
+7,500
+14% +$28K
GATO
10515
PUT
DELISTED
Gatos Silver, Inc.
GATO
$209K ﹤0.01%
72,900
-8,600
-11% -$30.2K
BFX
10516
DELISTED
BowFlex Inc.
BFX
$209K ﹤0.01%
119,552
+29,966
+33% +$82.9K
CBZ icon
10517
CALL
CBIZ
CBZ
$2.96B
$208K ﹤0.01%
+5,200
New +$210K
GSAT icon
10518
PUT
Globalstar
GSAT
$10.7B
$208K ﹤0.01%
11,300
-3,900
-26% -$72.4K
INDL icon
10519
PUT
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.9M
$208K ﹤0.01%
4,900
-7,500
-60% -$369K
KDRN icon
10520
Kingsbarn Tactical Bond ETF
KDRN
$2.31M
$208K ﹤0.01%
9,387
-518
-5% -$11.8K
TBHC
10521
DELISTED
The Brand House Collective
TBHC
$208K ﹤0.01%
59,104
+38,691
+190% +$248K
WERN icon
10522
CALL
Werner Enterprises
WERN
$2.33B
$208K ﹤0.01%
5,400
-1,300
-19% -$51.2K
PGRU
10523
PUT
DELISTED
PropertyGuru Group Limited
PGRU
$208K ﹤0.01%
46,300
-224,800
-83% -$1.42M
ARR
10524
CALL
Armour Residential REIT
ARR
$2.37B
$207K ﹤0.01%
5,880
-3,340
-36% -$124K
BKSE icon
10525
BNY Mellon US Small Cap Core Equity ETF
BKSE
$90.7M
$207K ﹤0.01%
+8,259
New +$226K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.